Li_2021_Pharmaceutics_13_

Reference

Title : Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside\/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection - Li_2021_Pharmaceutics_13_
Author(s) : Li J , Liu S , Shi J , Zhu HJ
Ref : Pharmaceutics , 13 : , 2021
Abstract : Li_2021_Pharmaceutics_13_
ESTHER : Li_2021_Pharmaceutics_13_
PubMedSearch : Li_2021_Pharmaceutics_13_
PubMedID: 34683949
Gene_locus related to this paper: human-CTSA

Related information

Gene_locus related to this paper: human-CTSA

Citations formats

Li J, Liu S, Shi J, Zhu HJ (2021)
Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside\/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection
Pharmaceutics 13 :

Li J, Liu S, Shi J, Zhu HJ (2021)
Pharmaceutics 13 :